Detalhe da pesquisa
1.
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Lancet Oncol
; 12(6): 527-39, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21570352
2.
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Lancet Oncol
; 8(12): 1071-1078, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18024211
3.
An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Breast Cancer Res
; 9(3): R38, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17573968
4.
Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Lancet Oncol
; 12(2): 116, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21277543
5.
BCL9/9L-ß-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.
EBioMedicine
; 2(12): 1932-43, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26844272
6.
Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.
Cancer Res
; 70(16): 6619-28, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20682801
7.
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.
Nat Med
; 15(1): 68-74, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19122658